- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x GOL: GLYCEROL(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
SO4.4: 5 residues within 4Å:- Chain A: I.46, F.193, L.194, R.227, R.270
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:L.194
- Salt bridges: A:R.227, A:R.270
SO4.13: 6 residues within 4Å:- Chain B: D.44, I.46, G.192, L.194, R.227, R.270
2 PLIP interactions:2 interactions with chain B- Salt bridges: B:R.227, B:R.270
- 7 x CPS: 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE(Non-covalent)
CPS.5: 10 residues within 4Å:- Chain A: N.399, G.405, H.406, A.409
- Chain B: Y.378, L.381, C.385, I.412, Y.413, Y.416
10 PLIP interactions:4 interactions with chain A, 6 interactions with chain B- Hydrophobic interactions: A:A.409, B:Y.378, B:L.381, B:I.412, B:Y.413, B:Y.416
- Hydrogen bonds: A:N.399
- Water bridges: A:Y.378, A:Y.378, B:Y.378
CPS.6: 11 residues within 4Å:- Chain A: Y.378, L.381, C.385, I.412, Y.413, Y.416
- Chain B: N.399, V.402, G.405, H.406, A.409
12 PLIP interactions:9 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:Y.378, A:L.381, A:I.412, A:Y.413, A:Y.416, B:A.409
- Water bridges: A:Y.378, A:Y.378, A:Y.413, A:Y.413, B:Y.378, B:H.406
CPS.7: 7 residues within 4Å:- Chain A: F.446, P.447, Y.450
- Chain B: P.428, L.431, L.432
- Ligands: CPS.8
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.446, A:Y.450, A:Y.450, A:Y.450, B:L.431, B:L.432
CPS.8: 8 residues within 4Å:- Chain A: Y.439, C.442, S.443, F.446, P.447
- Chain B: G.435
- Ligands: CPS.7, CPS.14
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.446, A:F.446
- Hydrogen bonds: A:S.443
CPS.9: 7 residues within 4Å:- Chain A: K.317, L.318, G.321, I.322, A.330, E.333, S.337
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:E.333
- Hydrogen bonds: A:L.318, A:G.321, A:S.337, A:S.337
CPS.14: 9 residues within 4Å:- Chain A: G.435, Y.439
- Chain B: Y.439, C.442, S.443, F.446, P.447
- Ligands: CPS.8, CPS.15
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:F.446
CPS.15: 6 residues within 4Å:- Chain A: P.428, L.431, L.432
- Chain B: F.446, Y.450
- Ligands: CPS.14
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain B- Hydrophobic interactions: A:P.428, A:L.432, B:F.446, B:Y.450, B:Y.450, B:Y.450
- 2 x EKV: N-[(3-{[dimethyl(2-methylphenyl)silyl]methoxy}phenyl)methyl]-N-ethyl-6-methoxy-6-methylhepta-2,4-diyn-1-amine(Non-covalent)
EKV.10: 27 residues within 4Å:- Chain A: F.50, Q.52, Y.79, I.81, I.92, Y.94, A.206, L.208, L.217, Y.219, P.299, L.300, G.302, L.353, L.357, F.361, C.375, F.379, P.389, V.390, L.392, L.393, L.403, H.406, F.407, V.410
- Ligands: FAD.11
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:F.50, A:F.50, A:Y.79, A:I.92, A:A.206, A:L.208, A:L.217, A:Y.219, A:Y.219, A:Y.219, A:L.353, A:L.357, A:L.357, A:F.361, A:F.379, A:P.389, A:H.406, A:V.410
- Hydrogen bonds: A:Y.79
EKV.16: 27 residues within 4Å:- Chain B: F.50, Y.79, I.81, Y.94, A.206, E.207, L.208, L.217, Y.219, P.299, L.300, T.301, G.302, L.353, L.357, F.361, C.375, F.379, P.389, V.390, L.392, L.393, L.403, H.406, F.407, V.410
- Ligands: FAD.17
18 PLIP interactions:18 interactions with chain B- Hydrophobic interactions: B:F.50, B:F.50, B:Y.79, B:A.206, B:L.208, B:L.217, B:Y.219, B:Y.219, B:L.353, B:L.357, B:L.357, B:F.361, B:F.379, B:F.379, B:P.389, B:V.390, B:H.406, B:V.410
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.11: 31 residues within 4Å:- Chain A: G.14, A.15, G.16, V.17, L.18, I.36, E.37, R.38, R.45, V.47, G.48, E.49, F.50, R.118, G.132, V.133, V.134, A.168, D.169, G.170, F.190, M.272, P.273, G.291, D.292, P.299, G.302, G.303, G.304, M.305
- Ligands: EKV.10
32 PLIP interactions:32 interactions with chain A- Hydrophobic interactions: A:V.47, A:V.47, A:F.190, A:M.272, A:P.299
- Hydrogen bonds: A:A.15, A:A.15, A:V.17, A:L.18, A:R.38, A:R.38, A:G.48, A:E.49, A:F.50, A:F.50, A:R.118, A:V.134, A:V.134, A:D.292, A:G.304, A:M.305
- Water bridges: A:G.16, A:G.19, A:R.45, A:H.110, A:D.292, A:A.293, A:R.297, A:R.297, A:G.303, A:T.306
- Salt bridges: A:R.45
FAD.17: 31 residues within 4Å:- Chain B: G.14, A.15, G.16, V.17, L.18, I.36, E.37, R.38, R.45, V.47, G.48, E.49, F.50, R.118, G.132, V.133, V.134, A.168, D.169, G.170, F.175, M.272, P.273, G.291, D.292, P.299, G.302, G.303, G.304, M.305
- Ligands: EKV.16
29 PLIP interactions:29 interactions with chain B- Hydrophobic interactions: B:V.47, B:M.272, B:P.299
- Hydrogen bonds: B:A.15, B:A.15, B:V.17, B:L.18, B:R.38, B:R.38, B:G.48, B:E.49, B:F.50, B:F.50, B:R.118, B:V.134, B:V.134, B:D.292, B:G.304, B:M.305
- Water bridges: B:G.16, B:G.19, B:E.49, B:A.293, B:R.297, B:R.297, B:G.303, B:T.306, B:A.308
- Salt bridges: B:R.45
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Padyana, A.K. et al., Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase. Nat Commun (2019)
- Release Date
- 2019-01-16
- Peptides
- Squalene monooxygenase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x GOL: GLYCEROL(Non-functional Binders)
- 2 x SO4: SULFATE ION(Non-functional Binders)
- 7 x CPS: 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE(Non-covalent)
- 2 x EKV: N-[(3-{[dimethyl(2-methylphenyl)silyl]methoxy}phenyl)methyl]-N-ethyl-6-methoxy-6-methylhepta-2,4-diyn-1-amine(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Padyana, A.K. et al., Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase. Nat Commun (2019)
- Release Date
- 2019-01-16
- Peptides
- Squalene monooxygenase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B